Gene · 28996
Papers1,691
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 1,691
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Single-Cell and Transcriptome-Based Immune Cell-Related Prognostic Model in Clear Cell Renal Cell Carcinoma. | J Oncol | 2023 | 36925653 | PubTator, text mining | PubMed |
| N6-methyladenosine (m6A) as a regulator of carcinogenesis and drug resistance by targeting epithelial-mesenchymal transition and cancer stem cells. | Heliyon | 2023 | 36915498 | PubTator, text mining | PubMed |
| Analysis of gene expression profiles in Alzheimer's disease patients with different lifespan: A bioinformatics study focusing on the disease heterogeneity. | Front Aging Neurosci | 2023 | 36909942 | PubTator, text mining | PubMed |
| Epigenetic perspectives associated with COVID-19 infection and related cytokine storm: an updated review. | Infection | 2023 | 36906872 | PubTator, text mining | PubMed |
| Long noncoding RNA/circular RNA regulates competitive endogenous RNA networks in rheumatoid arthritis: molecular mechanisms and traditional Chinese medicine therapeutic significances. | Ann Med | 2023 | 36905646 | PubTator, text mining | PubMed |
| HIPK2 in Angiogenesis: A Promising Biomarker in Cancer Progression and in Angiogenic Diseases. | Cancers (Basel) | 2023 | 36900356 | PubTator, text mining | PubMed |
| Regulatory mechanisms of microRNAs in endocrine disorders and their therapeutic potential. | Front Genet | 2023 | 36896239 | PubTator, text mining | PubMed |
| Silmitasertib (CX-4945), a Clinically Used CK2-Kinase Inhibitor with Additional Effects on GSK3β and DYRK1A Kinases: A Structural Perspective. | J Med Chem | 2023 | 36883902 | PubTator, text mining | PubMed |
| A molecular study of pediatric pilomyxoid and pilocytic astrocytomas: Genome-wide copy number screening, retrospective analysis of clinicopathological features and long-term clinical outcome. | Front Oncol | 2023 | 36860324 | PubTator, text mining | PubMed |
| ERβ1 Sensitizes and ERβ2 Desensitizes ERα-Positive Breast Cancer Cells to the Inhibitory Effects of Tamoxifen, Fulvestrant and Their Combination with All-Trans Retinoic Acid. | Int J Mol Sci | 2023 | 36835157 | PubTator, text mining | PubMed |
| Extracellular Vesicles in Colorectal Cancer: From Tumor Growth and Metastasis to Biomarkers and Nanomedications. | Cancers (Basel) | 2023 | 36831450 | PubTator, text mining | PubMed |
| HIPK2 as a Novel Regulator of Fibrosis. | Cancers (Basel) | 2023 | 36831402 | PubTator, text mining | PubMed |
| The RUNX/CBFβ Complex in Breast Cancer: A Conundrum of Context. | Cells | 2023 | 36831308 | PubTator, text mining | PubMed |
| KinFams: De-Novo Classification of Protein Kinases Using CATH Functional Units. | Biomolecules | 2023 | 36830646 | PubTator, text mining | PubMed |
| Autophagy-mediated circHIPK2 promotes lipopolysaccharide-induced astrocytic inflammation via SIGMAR1. | Int Immunopharmacol | 2023 | 36827915 | PubTator, text mining | PubMed |
| Tumor Suppressor p53 Down-Regulates Programmed Cell Death Protein 4 (PDCD4) Expression. | Curr Oncol | 2023 | 36826085 | PubTator, text mining | PubMed |
| Genetic mutation of SLC6A20 (c.1072T > C) in a family with nephrolithiasis: A case report. | Open Med (Wars) | 2023 | 36820062 | PubTator, text mining | PubMed |
| HIV-Associated Nephropathy in 2022. | Glomerular Dis | 2023 | 36816427 | PubTator, text mining | PubMed |
| Roles of hypoxia-inducible factor in hepatocellular carcinoma under local ablation therapies. | Front Pharmacol | 2023 | 36814489 | PubTator, text mining | PubMed |
| Emerging roles of m6A RNA modification in cancer therapeutic resistance. | Exp Hematol Oncol | 2023 | 36810281 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/28996/papers?page=11